HLYK · XBRL financial data

HealthLynked financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (HLYK's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25†Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue	1,333	931*	1,004	795	590	619*	—	—	—	—	—	—
Selling, general and administrative	768	918*	999	861	632	546*	629	452	501	454*	847	517
Total operating expenses	2,517	2,043*	2,182	1,875	2,261	1,368*	1,392	1,028	918	841*	1,124	789
Operating income (loss)	(1,185)	(1,112)*	(1,178)	(1,079)	(1,671)	(749)*	(617)	(435)	(530)	(531)*	(701)	(539)
Interest expense	(45)*	(1)*	6	—	—	—	—	—	—	—	—	—
Net income (loss)	(175)	(1,286)*	(1,388)	(1,540)	(1,973)	(1,230)*	(1,051)	(701)	(852)	(676)*	(1,621)	(820)
Earnings per share, basic USD per share	0.00	0.00*	0.00	(0.01)	(0.01)	0.00*	0.00	0.00	(0.30)	—	(0.56)	(0.28)
Earnings per share, diluted USD per share	0.00	0.00*	0.00	(0.01)	(0.01)	0.00*	0.00	0.00	(0.30)	—	(0.56)	(0.28)
Weighted average shares, basic thousands of shares	265,519	268,941*	280,484	281,789	281,947	281,947*	281,947	281,947	2,832	—	2,902	2,942
Weighted average shares, diluted thousands of shares	265,519	268,941*	280,484	281,789	281,947	281,947*	281,947	281,947	2,832	—	2,902	2,942

† Share count changed about 1/98 in the period ending 2025-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal quarters (HLYK's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25†Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	51	247	23	173	15	76	22	20	11	37	24	13
Accounts receivable	42	21	34	39	26	—	—	—	—	—	—	—
Inventory	142	133	136	96	79	45	32	28	32	18	18	18
Prepaid and other current assets	78	50	40	35	42	57	50	48	37	33	33	50
Total current assets	2,202	656	1,896	2,006	1,824	1,641	1,568	1,559	1,543	1,552	1,539	1,545
Property and equipment, net	322	291	264	234	205	177	149	121	101	75	49	38
Right-of-use asset	519	936	854	799	679	361	297	154	120	76	38	10
Total assets	5,689	4,280	3,891	3,860	2,758	2,223	2,057	1,848	1,765	1,702	1,626	1,593
Accrued liabilities	132	91	175	73	57	90	138	78	102	177	209	182
Total current liabilities	3,360	2,412	2,695	3,396	3,807	4,690	5,600	6,126	6,744	7,013	8,198	8,896
Lease liability, non-current	291	613	525	439	351	154	111	16	4	1	—	—
Total liabilities	4,128	3,475	3,669	4,284	4,691	5,352	6,195	6,601	7,198	7,464	8,648	9,346
Accumulated deficit	(40,747)	(42,033)	(43,421)	(44,961)	(46,934)	(48,165)	(49,216)	(49,917)	(50,768)	(50,539)	(52,197)	(53,017)
Total stockholders' equity	1,561	805	221	(425)	(1,933)	(3,129)	(4,137)	(4,752)	(5,433)	(5,762)	(7,022)	(7,753)
Total liabilities and equity	5,689	4,280	3,891	3,860	2,758	2,223	2,057	1,848	1,765	1,702	1,626	1,593
Common shares outstanding (cover page) thousands of shares	267,429	281,065	281,942	281,947	281,947	281,948	281,947	281,947	2,866	2,941	2,941	2,953

† Share count changed about 1/98 in the period ending 2025-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal quarters (HLYK's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25†Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(175)	(1,286)*	(1,388)	(1,540)	(1,973)	(1,230)*	(1,051)	(701)	(852)	(676)*	(1,621)	(820)
Stock-based compensation	56*	79*	93	87*	12*	18*	7	5*	53*	93*	298	88*
Depreciation and amortization	87*	88*	87	85*	83*	28*	28	27*	20*	26*	26	10*
Net cash from operating activities	(1,249)*	(1,192)*	(855)	(859)*	(1,037)*	(744)*	(433)	(418)*	(444)*	(419)*	(222)	(350)*
Purchases of property and equipment	—	0*	3	0*	0*	0*	—	—	—	—	—	—
Net cash from investing activities	359*	1,186*	(3)	0*	0*	425*	—	—	—	year only	—	—
Proceeds from issuing common stock	0*	375*	355	50*	0*	0*	10	0*	0*	20*	—	—
Proceeds from issuing equity	—	—	—	—	—	year only	—	—	—	year only	—	—
Net cash from financing activities	23*	202*	634	1,008*	879*	380*	379	415*	435*	321*	209	339*

† Share count changed about 1/98 in the period ending 2025-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

SIC 8011 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.

How peers are chosen

SIC 8011 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Fewer than three companies fall in that range, so the list adds same-SIC (8011) companies nearest in public float, each marked “added: same SIC”.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.
A cell reading “year only” links to a 10-K that gives only the full year: without all three earlier quarters there is no fourth quarter to work out, and the year total is never shown as a quarter.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
HealthLynked	13	not reported	(350)*	3.0M	0.0 quarters	Q2 FY26 10-QJun 30, 2026
Cardiff Lexingtonadded: same SIC	218	2,160	(652)*	15.6M	0.3 quarters	Q2 FY26 10-QJun 30, 2026
SBC Medical Group Holdingsadded: same SIC	184,311	49,188	22,509*	102.8M	—	Q2 FY26 10-QJun 30, 2026
Airsculpt Technologiesadded: same SIC	18,824	42,900	(1,238)*	72.1M	15.2 quarters	Q2 FY26 10-QJun 30, 2026
Starling Oncologyadded: same SIC	41,094	161,282	11,940*	101.9M	—	Q2 FY26 10-QJun 30, 2026
LifeMDadded: same SIC	25,142	47,281	(6,926)*	48.2M	3.6 quarters	Q2 FY26 10-QJun 30, 2026
Teladoc Healthadded: same SIC	849,909	605,102	106,458*	182.3M	—	Q3 FY26 10-QSep 30, 2026
Hims & Hers Healthadded: same SIC	609,811	753,214	(35,939)*	not reported	—	Q2 FY26 10-QJun 30, 2026
Aunaadded: same SIC	235,745	year only	year only	not reported	—	Q4 FY24 20-F/ADec 31, 2024

Not investment advice. Not affiliated with the U.S. SEC.